Home / Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated / Czechia
CZ ATC J07AH08 · updated 2 Nov 2026
Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated shortage in Czechia
Is there a Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated product is reported short in Czechia, the first since 1 Oct 2026. The company estimate for the return is 6 Nov 2026. Main reason: distribution or logistics.
Also short in Canada, Italy. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | MENQUADFI INJ SOL 1X0,5ML | Sanofi Winthrop Industrie, Gentilly | 1 Oct 2026 | 6 Nov 2026 | Distribution or logistics Kapacitní/distribuční důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.